Abstract:executive summary: This essay examines China's drive for innovation as part of its national development strategy and addresses the tensions China faces between retaining control and autonomy in relevant sciences and technologies and becoming a global leader in these fields. main argument The Chinese Communist Party (CCP) has assessed that the world is undergoing "profound changes unseen in a century" in part as a result of rapid advances in science and technology. The Covid-19 pandemic has heightened the impact of these changes and added to the disruption of the current global order. Such conditions present unique challenges and opportunities for China in the course of its national rejuvenation. Xi Jinping has accelerated the pursuit of China's rise as a great power, and the 14th Five-Year Plan highlights the country's capacity for innovation and to leverage science and technology in pursuit of that objective. Progress toward this goal, however, has been uneven. Although China aspires to be a new "high ground" in science and technology, the capacity for innovative Chinese technologies to go global may be undermined by a deficit of trust and transparency. If China does emerge as a leader in new frontiers of innovation in the course of the fourth industrial revolution, this shift could present significant implications for the future balance of power. policy implications • China's drive for innovation will continue to confront certain incongruities. While the CCP has prioritized innovation, the imperative of party control may undermine the necessary conditions for it. And while China has risen within and benefited from a world of open science, intense competition in the geopolitical environment is complicating that paradigm. • China and its technology companies have shown increasing technological prowess (e.g., in coping with the Covid-19 pandemic) but still face technical impediments to overcoming strangleholds in key areas, such as semiconductors, that act as chokepoints. • For the U.S. to sustain its traditional leadership in science and technology, it will need to revitalize and reinvest in innovation domestically.

Construction of China’s Strategic Science and Technology Forces Construction of China’s Strategic Science and Technology Forces from Research and Development of COVID-19 Vaccine from Research and Development of COVID-19 Vaccine

Innovation-driven trend shaping COVID-19 vaccine development in China

Constructed Recognition: How Nationalism Influences Public Acceptance of Domestic COVID-19 Vaccines in China

The problems and solutions concerning clinical medicine research in Healthy China 2020 program

Research and exploration on building national strategic science and technology strength in research universities

Challenges in the Development of a Vaccine Against COVID-19

Strategic Path for High-Quality Development of Construction Industry Driven by Digitalization

The COVID-19 Vaccines Evaluation Program: Implementation, Management, and Experiences, 2021-2023

Strengthening top–down design? Mapping science, technology and innovation policy developments in China in the age of COVID-19

Strategies and Advances in Combating COVID-19 in China

Study on the Experience of Public Health System Construction in China's COVID-19 Prevention

The Great Leap Development and Outlook of China’s Scientific and Technological Strength (2000—2035)

Research and development of Chinese anti-COVID-19 drugs

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation

SARS-CoV-2 Vaccine Development and Challenges

Advances in COVID-19 Mrna Vaccine Development

China's Drive for Innovation within a World of Profound Changes

The research foundation for COVID-19 vaccine development

Strategy for the development of AIDS vaccine against Chinese HIV-1 subtypes and recent progress——the introduction of the project supported by the National Science and Technology Key Project on Major Infectious Diseases

The COVID-19 Vaccines: Recent Development, Challenges and Prospects

Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects